284 related articles for article (PubMed ID: 22045171)
1. Lymphadenectomy for bladder cancer: indications and controversies.
Burkhard FC; Roth B; Zehnder P; Studer UE
Urol Clin North Am; 2011 Nov; 38(4):397-405, v. PubMed ID: 22045171
[TBL] [Abstract][Full Text] [Related]
2. Role of lymphadenectomy for prostate cancer: indications and controversies.
La Rochelle JC; Amling CL
Urol Clin North Am; 2011 Nov; 38(4):387-95, v. PubMed ID: 22045170
[TBL] [Abstract][Full Text] [Related]
3. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of minimally invasive lymphadenectomy in bladder and prostate cancer surgery.
Hakimi AA; Ghavamian R
Urol Clin North Am; 2011 Nov; 38(4):407-18, v. PubMed ID: 22045172
[TBL] [Abstract][Full Text] [Related]
5. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
6. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
7. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
[TBL] [Abstract][Full Text] [Related]
8. Lymph node dissection in bladder cancer. Impact on staging and prognosis.
Jensen JB
Dan Med J; 2012 Dec; 59(12):B4559. PubMed ID: 23290294
[TBL] [Abstract][Full Text] [Related]
9. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
[TBL] [Abstract][Full Text] [Related]
10. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
Wright JL; Lin DW; Porter MP
Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
[TBL] [Abstract][Full Text] [Related]
11. The role of lymphadenectomy in high-grade invasive bladder cancer.
Stein JP; Skinner DG
Urol Clin North Am; 2005 May; 32(2):187-97. PubMed ID: 15862616
[TBL] [Abstract][Full Text] [Related]
12. Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
Abdollah F; Sun M; Schmitges J; Djahangirian O; Tian Z; Jeldres C; Perrotte P; Shariat SF; Montorsi F; Karakiewicz PI
BJU Int; 2012 Apr; 109(8):1147-54. PubMed ID: 21883849
[TBL] [Abstract][Full Text] [Related]
13. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
Lee D; Yoo S; You D; Hong B; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY; Jeong IG
Urol Oncol; 2017 Apr; 35(4):151.e1-151.e7. PubMed ID: 28139370
[TBL] [Abstract][Full Text] [Related]
14. Extended lymphadenectomy in bladder cancer.
Dorin RP; Skinner EC
Curr Opin Urol; 2010 Sep; 20(5):414-20. PubMed ID: 20657290
[TBL] [Abstract][Full Text] [Related]
15. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
17. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival.
Jensen JB; Ulhøi BP; Jensen KM
Int J Urol; 2012 Jan; 19(1):39-47. PubMed ID: 22050425
[TBL] [Abstract][Full Text] [Related]
18. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
[TBL] [Abstract][Full Text] [Related]
19. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.
Herr HW; Bochner BH; Dalbagni G; Donat SM; Reuter VE; Bajorin DF
J Urol; 2002 Mar; 167(3):1295-8. PubMed ID: 11832716
[TBL] [Abstract][Full Text] [Related]
20. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?
Koppie TM; Vickers AJ; Vora K; Dalbagni G; Bochner BH
Cancer; 2006 Nov; 107(10):2368-74. PubMed ID: 17041887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
